Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab

Statin-induced immune-mediated necrotising myopathy (IMNM) is a rare but increasingly recognised myositis. Many cases have positive antibodies to 3-hydroxy-3-methylglutaryl coenzyme A reductase (anti-HMGCR). The current treatment is ceasing the statin, but often immunosuppressive therapy is required...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Case Rep
Hlavní autoři: Zhang, Wenwen, Prince, Henry Miles, Reardon, Katrina
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2019
Témata:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6887445/
https://ncbi.nlm.nih.gov/pubmed/31791994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-232406
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky